title: FDA takes slow road toward withdrawal of drug approved with fast-track process.
authors.forename: Mike
authors.initials: M
authors.lastname: Mitka
mesh_terms: D058646:Adrenergic alpha-1 Receptor Agonists / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D017277:Drug Approval; D004345:Drug Industry; D006801:Humans; D007024:Hypotension, Orthostatic / Q000188:drug therapy; D008879:Midodrine / Q000627:therapeutic use*; D056737:Safety-Based Drug Withdrawals; D013997:Time Factors; D014481:United States; D014486:United States Food and Drug Administration
chemical_list: D058646:Adrenergic alpha-1 Receptor Agonists; D008879:Midodrine